Literature DB >> 9446670

Functional characterization of L-selectin ligands on human neutrophils and leukemia cell lines: evidence for mucinlike ligand activity distinct from P-selectin glycoprotein ligand-1.

C L Ramos1, M J Smith, K R Snapp, G S Kansas, G W Stickney, K Ley, M B Lawrence.   

Abstract

Recent reports have shown that leukocyte-leukocyte adhesion is dependent on L-selectin and that leukocyte recognition of L-selectin may be mediated by P-selectin glycoprotein ligand-1 (PSGL-1). We show that the specific attachment and rolling of human neutrophils and the leukemia cell lines HL-60 and U937 on immobilized, purified L-selectin under continuous shear stress is only partially inhibited by treatment with the PSGL-1 monoclonal antibody (MoAb), KPL1 (41% to 53% inhibition), suggesting that L-selectin ligand activity in addition to PSGL-1 may mediate myeloid cell rolling on L-selectin. K562 cells cotransfected with cDNAs encoding alpha (1,3)fucosyltransferase-VII (FucT-VII) and PSGL-1 rolled on L-selectin. Adhesion of FucT-VII-PSGL-1 transfectants to L-selectin was completely blocked by MoAb KPL1, indicating that both L-selectin and P-selectin bind similar sites on PSGL-1. In support of existence of a non-PSGL-1 L-selectin ligand activity on leukocytes, an HL-60 membrane preparation immunodepleted of PSGL-1 supported rolling of L-selectin, but not P-selectin transfectants. Treatment of HL-60 cells with O-sialoglycoprotein endopeptidase inhibited attachment and rolling on L-selectin and P-selectin. However, neuraminidase treatment completely blocked HL-60 rolling on L-selectin, but not P-selectin, suggesting L-selectin and P-selectin ligand activities have different contributions of sialic acid. These findings indicate that myeloid cells express sialylated, O-linked glycoprotein ligand activity independent of PSGL-1 that supports L-selectin-mediated rolling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446670

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  A direct comparison of selectin-mediated transient, adhesive events using high temporal resolution.

Authors:  M J Smith; E L Berg; M B Lawrence
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Identification of nucleolin as a new L-selectin ligand.

Authors:  G Harms; R Kraft; G Grelle; B Volz; J Dernedde; R Tauber
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

Review 3.  Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors:  Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

4.  Comparison of PSGL-1 microbead and neutrophil rolling: microvillus elongation stabilizes P-selectin bond clusters.

Authors:  Eric Y H Park; McRae J Smith; Emily S Stropp; Karen R Snapp; Jeffrey A DiVietro; William F Walker; David W Schmidtke; Scott L Diamond; Michael B Lawrence
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

5.  An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation.

Authors:  Akiko Shigeta; Masanori Matsumoto; Thomas F Tedder; John B Lowe; Masayuki Miyasaka; Takako Hirata
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

6.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo.

Authors:  E E Eriksson; X Xie; J Werr; P Thoren; L Lindbom
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

Review 8.  The role of platelets in acute lung injury (ALI).

Authors:  Alexander Zarbock; Klaus Ley
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.